Thromb Haemost 1984; 51(03): 321-325
DOI: 10.1055/s-0038-1661092
Original Article
Schattauer GmbH Stuttgart

Metabolism of Sodium Pentosan Polysulphate in Man – Catabolism of Iodinated Derivatives

I R MacGregor
1   The Scottish National Blood Transfusion Service Headquarters Unit Laboratory, Edinburgh, Scotland, U.K.
,
J Dawes
2   The MRC/SNBTS Blood Components Assay Group, Edinburgh, Scotland, U.K.
,
L Paton
3   The S-E Scotland Blood Transfusion Service, Royal Infirmary, Edinburgh, Scotland, U.K.
,
D S Pepper
1   The Scottish National Blood Transfusion Service Headquarters Unit Laboratory, Edinburgh, Scotland, U.K.
,
C V Prowse
3   The S-E Scotland Blood Transfusion Service, Royal Infirmary, Edinburgh, Scotland, U.K.
,
M Smith
4   The Department of Medical Physics and Medical Engineering, Royal Infirmary, Edinburgh, Scotland, U.K.
› Author Affiliations
Further Information

Publication History

Received 15 November 1983

Accepted 08 March 1984

Publication Date:
19 July 2018 (online)

Zoom Image

Summary

An iodinated derivative of the heparin analogue SP54 has been prepared and used in conjunction with unlabelled SP54 to study the catabolism and organ distribution of this potential antithrombotic agent in healthy human volunteers. As observed previously with 125I-heparin, we found that the 125I-SP54 was rapidly cleared from the circulation, returning later in a desulphated form. Organ distribution studies with 123I-SP54 suggested that the liver and spleen were major sites of desulphation. Gel filtration and Polybrene binding showed the presence of sulphated macromolecular SP54 and desulphated macromolecular and depolymerised SP54 in post-injection urines. No depolymerised material was present in plasma suggesting depolymerisation occurs in the kidney.